Clonidine potentiates the neuropathic pain-relieving action of MK-801 while preventing its neurotoxic and hyperactivity side effects

Brain Research

Volumn 781, Issue 1-2, 1998, Pages 202-211

  Jevtovic Todorovic, V ^a   Wozniak, D F ^a   Powell, S ^a   Nardi, A ^a   Olney, J W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Activity; Clonidine; MK 801; Neuropathic pain; Neurotoxicity; Rat

Indexed keywords

CLONIDINE; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG POTENTIATION; DRUG SAFETY; FEMALE; HYPERACTIVITY; NERVE LIGATION; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; SUBCUTANEOUS DRUG ADMINISTRATION; THERMAL STIMULATION;

ADRENERGIC ALPHA-AGONISTS; ANALYSIS OF VARIANCE; ANIMALS; CLONIDINE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; EXCITATORY AMINO ACID ANTAGONISTS; FEMALE; HINDLIMB; HYPERESTHESIA; HYPERKINESIS; NEURALGIA; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SCIATIC NERVE;

EID: 0032545715     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01247-X     Document Type: Article

References (33)

1. Aanonsen L.M., Wilcox G.L. Nociceptive action of excitatory amino acids in the mouse: effects of spinally administered opioids, phencyclidine and sigma agonists. J. Pharmacol. Exp. Ther. 243:1987;9-19.
2. Aanonsen L.M., Lei S., Wilcox G.L. Excitatory amino acid receptors and nociceptive neurotransmission in rat spinal cord. Pain. 41:1990;309-321.
3. Arceo R., Kaufman L., Feldman D., Ruben Z., Anderson T.D. A time sequence study of neuronal vacuoles induced by dextrorphan hydrochloride (DH) in the rat: light and electron microscopic observations. Toxicol. Pathol. 21:1992;596. (Abstr.).
4. Backonja M., Arndt G., Gombar K.A., Check B., Zimmermann M. Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. Pain. 56:1994;51-57.
5. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
6. Davar G., Hama A., Deykin A., Vos B., Maciewicz R. MK-801 blocks the development of thermal hyperalgesia in a rat model of experimental painful neuropathy. Brain Res. 553:1991;327-330.
7. Dickenson A.H., Sullivan A.F. Differential effects of excitatory amino acid antagonists on dorsal horn nociceptive neurones in the rat. Brain Res. 506:1990;31-39.
8. E. Domino, E. Luby, Abnormal mental states induced by phencyclidine as a model of schizophrenia, in: E. Domino (Ed.), PCP (Phencyclidine): Historical and Current Perspectives, Ann Arbor: NPP Books, 1981, pp. 401-418.
9. Eisenberg E., La Cross S., Strassman A.M. The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy. Neurosci. Lett. 187:1995;17-20.
10. Ellison G. Competitive and noncompetitive NMDA antagonists induce similar limbic degeneration. Neuro. Rep. 5:1994;2688-2692.
11. Farber N.B., Foster J., Duhan N.L., Olney J.W. A2 adrenergic agonists prevent NMDA antagonist neurotoxicity. Neuropsychopharmacology. 12:1995;347-349.
12. H.L. Fields, Painful Dysfunction of the Nervous System, in: H.L. Fields (Ed.), Pain, McGraw-Hill, 1987, pp. 133-170.
13. Fix A.S., Horn J.W., Wightman K.A., Johnson C.A., Long G.C., Storts R.W., Farber N.B., Wozniak D.F., Olney J.W. Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (Dizocilpine Maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp. Neurol. 123:1993;204-215.
14. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
15. Kamisaki Y., Hamada T., Maeda K., Ishimura M., Itoh T. Presynaptic alpha-2 adrenoceptors inhibit glutamate release from rat spinal cord synaptosomes. J. Neurochem. 60(2):1993;522-526.
16. S.H. Kim, N.B. Farber, M.T. Price, J.W. Olney, Clonidine suppresses MK801-induced acetylcholine release in rat posterior cingulate cortex: in vivo microdialysis study, Soc. Neurosci. Abst., (in press) 1997.
17. Kristensen J.D., Svensson B., Gordh T. The NMDA-receptor antagonist CPP abolishes neurogenic 'wind-up pain' after intrathecal administration in humans. Pain. 51:1992;249-253.
18. Krystal J.H., Karper L.P., Seibyl J.P., Freeman G.K., Delaney R., Bremner J.D., Heninger G.R., Bowers M.B., Charney D.S. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive and neuroendocrine responses. Arch. Gen. Psychiatry. 51:1994;199-214.
19. Lee Y., Yaksh T. Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model. Anesthesiology. 82:1995;741-748.
20. Mao J., Price D.D., Mayer D.J., Lu J., Hayes R.L. Intrathecal MK-801 and local nerve anesthesia synergistically reduce nociceptive behaviors in rats with experimental peripheral mononeuropathy. Brain Res. 576:1992;254-262.
21. Neugebauer V., Kornhuker J., Lucke T., Schaible H.G. The clinically available NMDA receptor antagonist memantine is antinociceptive on rat spinal neurons. Neuro. Rep. 4:1993;1259-1262.
22. Olney J.W., Labruyere J., Price M.T. Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science. 244:1989;1360-1362.
23. Olney J.W., Labruyere J., Wang G., Sesma M.A., Wozniak D.F., Price M.T. NMDA antagonist neurotoxicity: mechanism and protection. Science. 254:1991;1515-1518.
24. Olney J.W., Farber N.B. NMDA antagonists as neurotherapeutic drugs, psychotogens, neurotoxins and research tools for studying schizophrenia. Neuropsychopharmacology. 13:1995;335-345.
25. Reich D.L., Silvay G. Ketamine: an update on the first twenty years of clinical experience. Can. J. Anaesth. 36:1989;186-197.
26. Seltzer Z., Cohn S., Ginzburg R., Beilin B. Modulation of neuropathic pain behavior in rats by spinal disinhibition and NMDA receptor blockade of injury discharge. Pain. 45:1991;69-75.
27. Tricklebank M.D., Singh L., Oles R.J., Preston D., Iversen S.D. The behavioral effects of MK-801: A comparison with antagonists acting noncompetitively and competitively at the NMDA receptor. Eur. J. Pharmacol. 167:1989;1127-1135.
28. Ueda M., Oyama T., Kuraishi Y., Akaike A., Satoh M. Alpha-2 adrenoceptor-mediated inhibition of capsaicin-evoked release of glutamate from rat spinal dorsal horn slices. Neurosci. Lett. 188:1995;137-139.
29. L. Wilkinson, M.A. Hill, E. Vang, SYSTAT: Statistics, Version 5.2, Evanston, IL, 1992.
30. Wozniak D.F., Cicero T.J., Kettinger L. III, Meyer E.R. Paternal alcohol consumption in the rat impairs spatial learning performance in male offspring. Psychopharmacology. 105:1991;289-302.
31. Wozniak D.F., Olney J.W., Kettinger L. 3rd, Price M., Miller J.P. Behavioral effects of MK-801 in the rat. Psychopharmacology. 101:1990;47-56.
32. Yamamoto T., Yaksh T.L. Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain. 49:1992;121-128.
33. Zeigler D., Lynch S.A., Muir J., Benjamin J., Max M.B. Transdermal clonidine vs. placebo in painful diabetic neuropathy. Pain. 48:1992;403-408.